ArticleCancer medicine2025

Talquetamab-Related Dysgeusia in Multiple Myeloma Compared to BCMA-Targeted Bispecifics and High-Dose Melphalan.

Anna Fleischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.